Functional expression of carnitine/organic cation transporter OCTN1/SLC22A4 in mouse small intestine and liver

Drug Metabolism and Disposition

Volumn 38, Issue 10, 2010, Pages 1665-1672

  Sugiura, Tomoko ^a   Kato, Sayaka ^a   Shimizu, Takuya ^a   Wakayama, Tomohiko ^a   Nakamichi, Noritaka ^a   Kubo, Yoshiyuki ^a   Iwata, Daisuke ^a   Suzuki, Kazuhiro ^a   Soga, Tomoyoshi ^b   Asano, Masahide ^a   Iseki, Shoichi ^a   Tamai, Ikumi ^a   Tsuji, Akira ^a   Kato, Yukio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; INULIN; ORGANIC CATION TRANSPORTER 1; TETRYLAMMONIUM; THIONEINE; VERAPAMIL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG UPTAKE; FIRST PASS EFFECT; GASTROINTESTINAL ABSORPTION; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL; LIVER SINUSOID; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE;

ANIMALS; CARNITINE; CARRIER PROTEINS; CELLS, CULTURED; ERGOTHIONEINE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL ABSORPTION; INTESTINE, SMALL; LIVER; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; SUBSTRATE SPECIFICITY; TRITIUM;

MUS;

EID: 77957126905     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.110.032763     Document Type: Article

References (36)

1. Balimane PV, Tamai I, Guo A, Nakanishi T, Kitada H, Leibach FH, Tsuji A, and Sinko PJ (1998) Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir. Biochem Biophys Res Commun 250:246-251. (Pubitemid 28463863)
2. Banfield C, Gupta S, Marino M, Lim J, and Affrime M (2002) Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine. Clin Pharmacokinet 41:311-318. (Pubitemid 34533758)
3. Berry MN and Friend DS (1969) High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43:506-520.
4. Bedirli A, Sakrak O, Muhtaroglu S, Soyuer I, Guler I, Riza Erdogan A, and Sozuer EM (2004) Ergothioneine pretreatment protects the liver from ischemia-reperfusion injury caused by increasing hepatic heat shock protein 70. J Surg Res 122:96-102. (Pubitemid 39441239)
5. Brandsch M (2009) Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls. Expert Opin Drug Metab Toxicol 5:887-905.
6. Davies B and Morris T (1993) Physiological parameters in laboratory animals and humans. Pharm Res 10:1093-1095. (Pubitemid 23211439)
7. +-independent L-carnitine transporter in enterocytes basolateral membrane. J Cell Physiol 202:929-935.
8. Ey J, Schömig E, and Taubert D (2007) Dietary sources and antioxidant effects of ergothioneine. J Agric Food Chem 55:6466-6474. (Pubitemid 47280018)
9. Glaeser H, Bailey DG, Dresser GK, Gregor JC, Schwarz UI, McGrath JS, Jolicoeur E, Lee W, Leake BF, Tirona RG, et al. (2007) Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin Pharmacol Ther 81:362-370.
10. Groneberg DA, Döring F, Eynott PR, Fischer A, and Daniel H (2001) Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1. Am J Physiol Gastrointest Liver Physiol 281:G697-G704.
11. Gründemann D, Harlfinger S, Golz S, Geerts A, Lazar A, Berkels R, Jung N, Rubbert A, and Schömig E (2005) Discovery of the ergothioneine transporter. Proc Natl Acad Sci USA 102:5256-5261.
12. Hartman PE (1990) Ergothioneine as antioxidant. Methods Enzymol 186:310-318.
13. Horiuchi S, Takata K, and Morino Y (1985) Characterization of a membrane-associated receptor from rat sinusoidal liver cells that binds formaldehyde-treated serum albumin. J Biol Chem 260:475-481. (Pubitemid 15164076)
14. Kato Y, Kubo Y, Iwata D, Kato S, Sudo T, Sugiura T, Kagaya T, Wakayama T, Hirayama A, Sugimoto M, et al. (2010) Gene knockout and metabolome analysis of carnitine/organic cation transporter OCTN1. Pharm Res 27:832-840.
15. Kato Y, Miyazaki T, Kano T, Sugiura T, Kubo Y, and Tsuji A (2009) Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol. J Pharm Sci 98:2529-2539.
16. Kato Y, Sai Y, Yoshida K, Watanabe C, Hirata T, and Tsuji A (2005) PDZK1 directly regulates the function of organic cation/carnitine transporter OCTN2. Mol Pharmacol 67:734-743. (Pubitemid 40365320)
17. Kato Y, Sugiura M, Sugiura T, Wakayama T, Kubo Y, Kobayashi D, Sai Y, Tamai I, Iseki S, and Tsuji A (2006) Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse. Mol Pharmacol 70:829-837.
18. Kobayashi D, Nozawa T, Imai K, Nezu J, Tsuji A, and Tamai I (2003) Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J Pharmacol Exp Ther 306:703-708.
19. Li F, Maag H, and Alfredson T (2008) Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting. J Pharm Sci 97:1109-1134.
20. Lilja JJ, Raaska K, and Neuvonen PJ (2005a) Effects of grapefruit juice on the pharmacokinetics of acebutolol. Br J Clin Pharmacol 60:659-663. (Pubitemid 41705387)
21. Lilja JJ, Raaska K, and Neuvonen PJ (2005b) Effects of orange juice on the pharmacokinetics of atenolol. Eur J Clin Pharmacol 61:337-340. (Pubitemid 41569306)
22. Mayumi T, Kawano H, Sakamoto Y, Suehisa E, Kawai Y, and Hama T (1978) Studies on ergothioneine. V. Determination by high performance liquid chromatography and application to metabolic research. Chem Pharm Bull (Tokyo) 26:3772-3778.
23. Melville DB (1958) L-Ergothioneine. Vitam Horm 17:155-204.
24. Nakashima E, Tsuji A, Mizuo H, and Yamana T (1984) Kinetics and mechanism of in vitro uptake of amino-β-lactam antibiotics by rat small intestine and relation to the intact-peptide transport system. Biochem Pharmacol 33:3345-3352. (Pubitemid 15203617)
25. Piyapolrungroj N, Li C, Pisoni RL, and Fleisher D (1999) Cimetidine transport in brush-border membrane vesicles from rat small intestine. J Pharmacol Exp Ther 289:346-353. (Pubitemid 29156048)
26. 1-adrenoceptor antagonist talinolol mediated by P-glycoprotein and organic anion transporting polypeptide (Oatp). Pharm Res 26:560-567.
27. Soul-Lawton J, Seaber E, On N, Wootton R, Rolan P, and Posner J (1995) Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrob Agents Chemother 39:2759-2764.
28. Spolarics Z (1998) Endotoxemia, pentose cycle, and the oxidant/antioxidant balance in the hepatic sinusoid. J Leukoc Biol 63:534-541.
29. States JC, Srivastava S, Chen Y, and Barchowsky A (2009) Arsenic and cardiovascular disease. Toxicol Sci 107:312-323.
30. Sugiura T, Kato Y, Wakayama T, Silver DL, Kubo Y, Iseki S, and Tsuji A (2008) PDZK1 regulates two intestinal solute carriers (Slc15a1 and Slc22a5) in mice. Drug Metab Dispos 36:1181-1188. (Pubitemid 351717477)
31. Tamai I, Nakanishi T, Kobayashi D, China K, Kosugi Y, Nezu J, Sai Y, and Tsuji A (2004) Involvement of OCTN1 (SLC22A4) in pH-dependent transport of organic cations. Mol Pharm 1:57-66.
32. Tamai I, Ohashi R, Nezu JI, Sai Y, Kobayashi D, Oku A, Shimane M, and Tsuji A (2000) Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 275:40064-40072. (Pubitemid 32064631)
33. Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M, and Tsuji A (1997) Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419:107-111. (Pubitemid 28011227)
34. Urban TJ, Brown C, Castro RA, Shah N, Mercer R, Huang Y, Brett CM, Burchard EG, and Giacomini KM (2008) Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin. Clin Pharmacol Ther 83:416-421. (Pubitemid 351272627)
35. Yabuuchi H, Tamai I, Nezu J, Sakamoto K, Oku A, Shimane M, Sai Y, and Tsuji A (1999) Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther 289:768-773. (Pubitemid 29191230)
36. Yokogawa K, Higashi Y, Tamai I, Nomura M, Hashimoto N, Nikaido H, Hayakawa J, Miyamoto K, and Tsuji A (1999) Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice. J Pharmacol Exp Ther 289:224-230. (Pubitemid 29156033)